BNGO
BNGO
NASDAQ · Life Sciences Tools & Services

Bionano Genomics Inc

$1.26
-0.01 (-0.79%)
As of May 16, 2:30 AM ET ·
Financial Highlights (FY 2026)
Revenue
54.83M
Net Income
-50,769,957
Gross Margin
46.2%
Profit Margin
-92.6%
Rev Growth
+0.8%
D/E Ratio
0.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 46.2% 46.2% 30.2% 30.2%
Operating Margin -116.9% -105.3% 15.6% 17.4%
Profit Margin -92.6% -88.0% 13.5% 12.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 54.83M 54.38M 4.56M 4.59M
Gross Profit 25.36M 25.15M 1.38M 1.39M
Operating Income -64,127,853 -57,234,299 710.4K 800.1K
Net Income -50,769,957 -45,312,337 617.9K 580.5K
Gross Margin 46.2% 46.2% 30.2% 30.2%
Operating Margin -116.9% -105.3% 15.6% 17.4%
Profit Margin -92.6% -88.0% 13.5% 12.6%
Rev Growth +0.8% +0.8% +4.6% -9.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 510.7K 510.7K 5.02M 4.32M
Total Equity 6.09M 6.09M 5.58M 6.22M
D/E Ratio 0.08 0.08 0.90 0.70
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -42,391,385 -39,936,350 871.5K 857.6K
Free Cash Flow 406.9K 381.9K